share_log

Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Green Ralph Elias

Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Green Ralph Elias

Vivos Therapeutics | 4:持股变动声明-董事 Green Ralph Elias
美股sec公告 ·  06/28 20:57
Moomoo AI 已提取核心信息
In a recent transaction, Ralph Elias Green engaged in the sale of shares from Vivos Therapeutics, Inc. (VVOS). The action took place on June 20, 2024. However, the specific details regarding the number of shares transacted, the nature of the shares, the transaction price, and the post-transaction shareholding were not disclosed. This information is critical for investors to assess the impact of the transaction on their investment decisions.
In a recent transaction, Ralph Elias Green engaged in the sale of shares from Vivos Therapeutics, Inc. (VVOS). The action took place on June 20, 2024. However, the specific details regarding the number of shares transacted, the nature of the shares, the transaction price, and the post-transaction shareholding were not disclosed. This information is critical for investors to assess the impact of the transaction on their investment decisions.
在最近的一笔交易中,Ralph Elias Green参股金融公司Vivos Therapeutics, Inc. (VVOS)的股份进行了出售。这次交易发生在2024年6月20日。然而,关于交易股数、股份性质、交易价格以及交易后的持股情况的具体细节没有披露。这些信息对于投资者评估交易对其投资决策的影响至关重要。
在最近的一笔交易中,Ralph Elias Green参股金融公司Vivos Therapeutics, Inc. (VVOS)的股份进行了出售。这次交易发生在2024年6月20日。然而,关于交易股数、股份性质、交易价格以及交易后的持股情况的具体细节没有披露。这些信息对于投资者评估交易对其投资决策的影响至关重要。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息